Cannabis Stocks Rally on Trump’s Plan to Reclassify Marijuana as Schedule III Drug
Tilray Brands led a sector-wide surge, jumping 28% in premarket trading after reports indicated former President Donald TRUMP will push to reclassify cannabis as a Schedule III substance. The move would mark a seismic shift for the $73.6 billion industry by easing banking restrictions and reducing regulatory burdens.
Federal reclassification could unlock institutional capital flows into cannabis equities and related crypto assets. Market observers note parallels to 2018's farm bill rally, when hemp legalization catalyzed a 300% run in related altcoins.
"This isn't just about plant-touching businesses anymore," said Merrick Okamoto, hedge fund manager at Poseidon Asset Management. "The real play is in blockchain-based supply chain tokens and payment rails that circumvent traditional banking bottlenecks."